1. Home
  2. CGEN vs SKLZ Comparison

CGEN vs SKLZ Comparison

Compare CGEN & SKLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • SKLZ
  • Stock Information
  • Founded
  • CGEN 1993
  • SKLZ 2012
  • Country
  • CGEN Israel
  • SKLZ United States
  • Employees
  • CGEN 74
  • SKLZ N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • SKLZ EDP Services
  • Sector
  • CGEN Health Care
  • SKLZ Technology
  • Exchange
  • CGEN Nasdaq
  • SKLZ Nasdaq
  • Market Cap
  • CGEN 125.3M
  • SKLZ 136.4M
  • IPO Year
  • CGEN 2000
  • SKLZ N/A
  • Fundamental
  • Price
  • CGEN $1.38
  • SKLZ $7.22
  • Analyst Decision
  • CGEN
  • SKLZ Buy
  • Analyst Count
  • CGEN 0
  • SKLZ 1
  • Target Price
  • CGEN N/A
  • SKLZ $14.00
  • AVG Volume (30 Days)
  • CGEN 238.3K
  • SKLZ 71.3K
  • Earning Date
  • CGEN 11-11-2025
  • SKLZ 11-06-2025
  • Dividend Yield
  • CGEN N/A
  • SKLZ N/A
  • EPS Growth
  • CGEN N/A
  • SKLZ N/A
  • EPS
  • CGEN N/A
  • SKLZ N/A
  • Revenue
  • CGEN $22,144,000.00
  • SKLZ $93,320,000.00
  • Revenue This Year
  • CGEN N/A
  • SKLZ $17.44
  • Revenue Next Year
  • CGEN $159.40
  • SKLZ $12.03
  • P/E Ratio
  • CGEN N/A
  • SKLZ N/A
  • Revenue Growth
  • CGEN N/A
  • SKLZ N/A
  • 52 Week Low
  • CGEN $1.13
  • SKLZ $3.54
  • 52 Week High
  • CGEN $2.66
  • SKLZ $9.11
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 41.92
  • SKLZ 39.79
  • Support Level
  • CGEN $1.39
  • SKLZ $7.21
  • Resistance Level
  • CGEN $1.47
  • SKLZ $7.54
  • Average True Range (ATR)
  • CGEN 0.06
  • SKLZ 0.28
  • MACD
  • CGEN -0.00
  • SKLZ -0.17
  • Stochastic Oscillator
  • CGEN 33.33
  • SKLZ 10.46

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About SKLZ Skillz Inc.

Skillz Inc is a mobile game development company. It is engaged in re-inventing competitive mobile gaming and thereby expanding the mobile gaming market. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The company's reportable business segments are; the Skillz segment and the Aarki segment. The majority of its revenue is generated from the Skillz segment which is an eSports gaming platform, enabling game developers to monetize their content through multi-player competition. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

Share on Social Networks: